During a House Democrats meeting on Wednesday morning, the caucus elected marijuana reform supporter Representative Jerry Nadler (D-NY) to be the party leader on the powerful Judiciary Committee.
Rep. Nadler has earned an “A+” rating on the NORML Scorecard for his support of ending the federal prohibition of marijuana, positive votes when given the opportunity, and his co-sponsorship of legislation including the Regulate Marijuana Like Alcohol Act in the previous session of Congress.
The current Chairman of the committee is Rep. Bob Goodlatte (R-VA), a longtime opponent of marijuana reform who has earned a “D” on the NORML scorecard for voting against reform amendments when given the opportunity. However, Rep. Goodlatte had announced earlier this year that he will not be running for reelection, which will leave a wide-open race on the Republican side who will be the top member in the next Congress.
Given the political climate, in order to secure hearings on legislation that would end prohibition, it is essential that the next Chairman of the Judiciary be willing to address the issue.
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
California is rolling out the green carpet. Twenty temporary adult use licenses were issued December 14, including one in San Diego County, the first day of the new program of regulated sales, as the state prepares to embrace legal marijuana starting January 1, 2018. Adult possession, cultivation and sharing have all been legal since the law […]
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Ben Carson slams drug war’s impact; Bill Nye on Schedule I; New Zealand MMj bill
Subscribers who value this daily dispatch enough to show their support with a few dollars helps me keep doing this. Please chip in, if you can afford it.
/ TOP THINGS TO KNOW
The U.S. Department of Veterans Affairs issued a new medical cannabis policy that continues to bar government doctors from recommending marijuana but encourages them to talk more openly with veterans about it.
U.S. Housing and Urban Development Sec. Ben Carson spoke about how enforcing the war on drugs undermines anti-poverty efforts.
Congresswoman Dina Titus (D-NV) slammed GOP congressional leaders for not undoing the 280E penalty on marijuana businesses as part of tax reform legislation.
Kentucky’s secretary of state spoke about her support for medical cannabis.
- “My hope is Kentucky won’t be the last state to address the issue, and I’m tired of sitting back and waiting for the general assembly to address the issue… Kentucky is perfectly situated. We have the best farmland and the best people to be able to grow, cultivate and dispense medical cannabis for pain relief.”
Oregon saw a rise in the number of teens seeking treatment in an emergency room or calling a poison center after ingesting marijuana last year.
Rhode Island’s medical cannabis patient count grew 17% over the past year.
California regulators are deciding how to grant water access to marijuana growers.
A Virginia representative filed a bill to extend that state’s current affirmative defense protection for CBD or THC-A oil to people with cancer.
The Reading, Pennsylvania City Council withdrew a proposed marijuana decriminalization ordinance.
Clark County, Nevada commissioners delayed a decision on whether to allow local standalone recreational marijuana stores.
Mexican health regulators ruled against allowing home cultivation of medical cannabis.
Reuters looks at a police squad responsible for many deaths in the bloody Philippines “drug war.”
Canadian Prime Minister Justin Trudeau said that marijuana legalization will roll out “next summer” and not necessarily on July 1.
Past allegations of misconduct by former Marijuana Policy Project Executive Director Rob Kampia are resurfacing amidst a national backlash against workplace sexual harassment and abuse. Former MPP Chief of Staff Alison Green says she now regrets the way she responded to Kampia’s behavior at the organization.
In a potentially related development, the Drug Policy Alliance seems to have removed its honorary board from its website in the past week. Former Congressman John Conyers (D-MI) and music mogul Russell Simmons, both recently accused of sexual misconduct, were (are?) members.
A National Cannabis Industry Association board member stepped down, and a newly hired chief of staff parted ways with the organization.
AAA is urging New Jersey to slow down its march toward legalizing marijuana.
/ SCIENCE & HEALTH
A study found that “the majority of patients…believed that medical marijuana is a valid treatment and that it does have a role in reducing postinjury and postoperative pain,” and “those patients who used marijuana during their recovery felt that it alleviated symptoms of pain and reduced their opioid intake.”
Here’s a look at how Pennsylvania hospitals and medical schools are getting involved in cannabis research.
/ OPINION & ANALYSIS
A poll found that 66% of Americans believe legalizing marijuana will help the economy and that 64% think the federal government should not enforce prohibition in states that allow cannabis.
Public Policy Polling had a little fun in a holiday survey: “Much like gay marriage or marijuana legalization, ‘Die Hard’ as a Christmas movie is very much a generational issue. If pace of change in opinion over last 2 years continues it will be seen as Christmas movie by 2025.”
The CannaInsider Cannabis Education Scholarship pays students to enroll in marijuana industry training programs.
Here’s a look at how California marijuana workers are increasingly joining unions.
Here’s a lengthy look at the demise of Tradiv, an aspiring “Amazon of the cannabis industry,” after its founder had a psychedelic religious experience.
The National Academies of Sciences, Engineering, and Medicine announced that a report on marijuana research topped its 2017 bestseller list.
Longtime Seattle Times marijuana reporter Bob Young left his journalism job to become a state historian.
The Associated Press looks at looming struggles between big and small marijuana growers in California.
Scientist Bill Nye says that marijuana’s Schedule I status is “not based in any science.”
The post V.A. issues updated medical cannabis policy for veterans (Newsletter: Dec. 20, 2017) appeared first on Marijuana Moment.
The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry.
British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic patients. Participants ingested 1000mg of plant-derived CBD per day.
Subjects in the CBD treatment group “had lower levels of positive psychotic symptoms and were more likely to have been rated as improved and as not severely unwell by the treating clinician” at the conclusion of the trial. CBD administration was also associated with “improvements in cognitive performance and in the level of overall functioning,” although these changes did not reach statistical significance.
“These findings suggest that CBD has beneficial effects in patients with schizophrenia,” authors concluded. “As CBD’s effects do not appear to depend on dopamine receptor antagonism, this agent may represent a new class of treatment for the disorder.”
Results of the prior clinical trial published in the journal Translational Psychiatry determined that CBD is superior to amisulpride, a potent anti-psychotic agent, in mitigating psychotic symptoms in schizophrenic patients.
An abstract of the study, “Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial,” appears online here.
One of the world’s most famous scientists says that the U.S. government’s classification of marijuana has absolutely nothing to do with science.
“Nobody’s really sure how it works, marijuana. Nobody’s exactly sure what it does,” he said in a new interview released on Tuesday. “And so there’s a very strong argument that keeping it as a Schedule I drug is not based in any science.”
Schedule I — most restrictive category under federal law — is supposed to be reserved for drugs with a high potential for abuse and no medical value.
“But people use marijuana and marijuana extracts for all sorts of medical applications, so you’ve got to think there’s something to it,” Nye said.
Researchers have often complained that keeping marijuana in Schedule I perpetuates extra hurdles that studies on other drugs don’t need to overcome.
In the new season of “Bill Nye Saves the World,” premiering December 29 on Netflix, the scientist is seen getting a medical cannabis recommendation and visiting a California dispensary.
But Nye doesn’t consume marijuana on camera. He does, however, play ultimate frisbee with teammates who are under the influence of cannabis, he said in the new interview with CNET.
In a separate interview released last month, Nye touted the benefits of legalization.
“I lived in Washington State for a long time, and Washington State legalized it in 2012. We legalized marijuana, we tax it,” he said. “We have a lot of tax revenue. It’s no longer criminalized. We don’t spend money on the police department. We spend money regulating the industry in the same way we regulate other substances.”
Photo courtesy of Gage Skidmore.
The post Bill Nye: Marijuana’s Federal Status ‘Not Based In Science’ appeared first on Marijuana Moment.
The United Nations’ public health arm, the World Health Organization, now officially agrees that naturally occurring cannabidiol (CBD), a non-psychotropic medicinal compound found in cannabis, does not meet the criteria necessary to be listed as a schedule 1 prohibited drug in the USA. The federal DEA has to contend that a drug meets three requirements for the […]
“The change will take some time, but that means a changed vision: those who have a substance abuse problem should be treated as ill, and not as criminals with classical sanctions such as fines and imprisonment”, said Sveinung Stensland, deputy chairman of the Storting Health Committee, following the vote.
Nicolas Wilkinson, the SV party’s health spokesman, told VG that parliament’s goal was to “stop punishing people who struggle, but instead give them help and treatment”. He says aim is to transfer responsibility for drug policy from the justice system to the health system.
The move follows a 2006 scheme drug that was intended to replace custodial sentences with treatment programs for drug addicts in the cities of Bergen and Oslo. Last year the scheme was rolled out to all Norwegian courts.
The National Organization for the Reform of Marijuana Laws, NORML, announces a new partnership with Curved Papers, Inc. to produce branded rolling papers which are now available online and at select stores nationwide.
These 100% hemp papers feature a curved edge that results in a more evenly rolled end product.
A portion of the proceeds from the papers goes directly to NORML in order to sustain our efforts in promoting legalized adult use, expanded medical availability, and other related advocacy efforts in the cannabis community.
The NORML rolling papers debuted as part of Rolling Stones’ “Weed for the Holidays” gift giving guide.
“Research in both animals and humans indicates that cannabidiol (CBD) has antipsychotic properties”, begins the study’s abstract. “The authors assessed the safety and effectiveness of CBD in patients with schizophrenia.”
In an exploratory double-blind parallel-group trial, patients with schizophrenia were “randomized in a 1:1 ratio to receive CBD (1000 mg/day; N=43) or placebo (N=45) alongside their existing antipsychotic medication.” Participants were “assessed before and after treatment using the Positive and Negative Syndrome Scale (PANSS), the Brief Assessment of Cognition in Schizophrenia (BACS), the Global Assessment of Functioning scale (GAF), and the improvement and severity scales of the Clinical Global Impressions Scale (CGI-I and CGI-S).”
After 6 weeks of treatment, compared with the placebo group, “the CBD group had lower levels of positive psychotic symptoms (PANSS: treatment difference=-1.4, 95% CI=-2.5, -0.2) and were more likely to have been rated as improved (CGI-I: treatment difference=-0.5, 95% CI=-0.8, -0.1) and as not severely unwell (CGI-S: treatment difference=-0.3, 95% CI=-0.5, 0.0) by the treating clinician.” Patients who received CBD “also showed greater improvements that fell short of statistical significance in cognitive performance (BACS: treatment difference=1.31, 95% CI=-0.10, 2.72) and in overall functioning (GAF: treatment difference=3.0, 95% CI=-0.4, 6.4). CBD was well tolerated, and rates of adverse events were similar between the CBD and placebo groups.”
The study concludes by stating that; “These findings suggest that CBD has beneficial effects in patients with schizophrenia. As CBD’s effects do not appear to depend on dopamine receptor antagonism, this agent may represent a new class of treatment for the disorder.”
The full study, published online by the U.S. National Institute of Health, can be found by clicking here.
The post Study Finds CBD has Beneficial Effects in Patients with Schizophrenia appeared first on TheJointBlog.
Proponents of the initiative must now collect around 13,500 signatures from registered North Dakota voters in order to put it to a vote of the people during the November, 2018 general election. The proposal would legalize the possession, personal cultivation and licensed distribution of recreational marijuana for everyone who is at least 21 years old.
The measure would also seal the records of anyone who’s been convicted of a marijuana-related crime that would be made legal under the initiative.
If advocates of the measure are successful in placing it on the ballot, and voters approve it, North Dakota would become the ninth state to legalize cannabis.
The post North Dakota Initiative to Legalize Marijuana Approved for Circulation by Secretary of State appeared first on TheJointBlog.
The legislation, titled the Misuse of Drugs (Decriminalization of Cannabis) Amendment Act and tabled by Minister of Social Development and Sport Zane DeSilva, will decriminalize the possession of up to seven grams of cannabis for personal use. Given the measure has been approved by Bermuda’s full Congress, it now goes to Governor John Rankin for consideration. Rankin is expected to sign the measure into law.
Under the proposed law cannabis possession up to seven grams would no longer be a criminal offense, though police would still have the authority to seize any cannabis found on a person. Charges could also still be applied if it’s determined that the cannabis was intended to be distributed, rather than consumed for personal use. The minister will also be tasked with determining regulations for substance abuse education or treatment for those caught possessing cannabis.
According to a Profiles of Bermuda poll released in 2015, 79% of voters in Bermuda support either decriminalizing or legalizing cannabis.
The post Bermuda Senate Approves Legislation to Decriminalize Cannabis, Sending it to Governor appeared first on TheJointBlog.
“This is a great Christmas present,” said California NORML director Dale Gieringer. “Licensing is an inevitable necessity of the modern bureaucratic state. I’m just happy to see the stores open and people be able to walk into a store — any adult including tourists and guests in California — and get cannabis just like they can get alcohol, cigarettes or all sorts of wonderful things in California.”
Altogether 20 licenses were issued to cannabis businesses located throughout the state, including multiple located in San Diego, Lynwood and San Jose. The most – seven in total – are located in Santa Cruz.
Below is a list of the 20 licenses issued yesterday (list provided by GreenState.com):
Legal Business Name Record Type Status Pure CA, LLC Adult-Use – Distributor Temporary License Active LYNWOOD CA 90262 Pure CA, LLC Medicinal – Distributor Temporary License Active LYNWOOD CA 90262 Buddy’s Cannabis Medicinal – Microbusiness Temporary License Active 1075 10TH ST N, BLDG, SAN JOSE CA 95112 HERBL Distribution Solutions Medicinal – Distributor Temporary License Active SANTA ROSA CA 95403 Buddy’s Cannabis Adult-Use – Microbusiness Temporary License Active 1075 10TH ST N, BLDG, SAN JOSE CA 95112 Golden State Sciences Medicinal – Distributor Temporary License Active KING CITY CA 93930 Yes Cannabis – Laboratory Testing Temporary License Active 181 HUNTINGTON DR W, SUITE 106, MONROVIA CA 91016 Torrey Holistics Medicinal – Retailer Temporary License Active 10671 ROSELLE ST, SUITE 100, SAN DIEGO CA 92121 KindPeoples (formerly KindPeoples Collective) Medicinal – Distributor Temporary License Active SANTA CRUZ CA 95060 KindPeoples (formerly KindPeoples Collective) Adult-Use – Distributor Temporary License Active SANTA CRUZ CA 95060 Torrey Holistics Adult-Use – Retailer Temporary License Active 10671 ROSELLE ST, SUITE 100, SAN DIEGO CA 92121 KindPeoples Medicinal – Retailer Temporary License Active 140 DUBOIS ST, SUITE C, SANTA CRUZ CA 95060 KindPeoples Adult-Use – Retailer Temporary License Active 140 DUBOIS ST, SUITE C, SANTA CRUZ CA 95060 KindPeoples (formerly KindPeoples Collective) Medicinal – Microbusiness Temporary License Active 140 Dubois ST, SUITE A, B, C, Santa Cruz CA 95060 KindPeoples (formerly KindPeoples Collective) Adult-Use – Retailer Temporary License Active 3600 SOQUEL AVE, SANTA CRUZ CA 95062 Hueneme Patient Consumer Coop Medicinal – Retailer Temporary License Active 501 CHANNEL ISLANDS BLVD W, SUITE 302, PORT HUENEME CA 93041 530 CANNABIS Adult-Use – Retailer Temporary License Active 1550 LOCUST AVE, SHASTA LAKE CA 96019 530 CANNABIS Medicinal – Retailer Temporary License Active 1550 LOCUST AVE, SHASTA LAKE CA 96019 KindPeoples (formerly KindPeoples Collective) Adult-Use – Microbusiness Temporary License Active 140 DUBOIS ST, SUITE A, B, C, SANTA CRUZ CA 95060 KindPeoples (formerly KindPeoples Collective) Medicinal – Retailer Temporary License Active
The post First Recreational Marijuana Business Licenses Issued in California appeared first on TheJointBlog.
The transition from under the table to over the counter is a convoluted journey for the cannabis trades. Where once outlaws grew in hidden dales and sold through a network of friends, now businesses are open to inspection and sales will soon be tracked from seed to sale. OSHA cannabis meeting: Wednesday January 31, 2018, 10 […]
The post Cal OSHA to hash out cannabis regulations in January appeared first on The Leaf Online.